HomeCompareSDXOF vs MRK

SDXOF vs MRK: Dividend Comparison 2026

SDXOF yields 6.16% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $31.2K in total portfolio value· pulled ahead in Year 2
10 years
SDXOF
SDXOF
● Live price
6.16%
Share price
$51.30
Annual div
$3.16
5Y div CAGR
-10%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$276.84
Full SDXOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SDXOF vs MRK

📍 MRK pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSDXOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SDXOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SDXOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SDXOF
Annual income on $10K today (after 15% tax)
$523.89/yr
After 10yr DRIP, annual income (after tax)
$235.31/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,093.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SDXOF + MRK for your $10,000?

SDXOF: 50%MRK: 50%
100% MRK50/50100% SDXOF
Portfolio after 10yr
$41.2K
Annual income
$5,037.49/yr
Blended yield
12.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SDXOF
Analyst Ratings
15
Buy
21
Hold
6
Sell
Consensus: Hold
Altman Z
4.1
Piotroski
8/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SDXOF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSDXOFMRK
Forward yield6.16%2.76%
Annual dividend / share$3.16$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-10%32.7%
Portfolio after 10y$25.6K$56.8K
Annual income after 10y$276.84$9,798.13
Total dividends collected$4.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: SDXOF vs MRK ($10,000, DRIP)

YearSDXOF PortfolioSDXOF Income/yrMRK PortfolioMRK Income/yrGap
1$11,255$554.70$11,206$366.19+$49.00SDXOF
2← crossover$12,568$525.11$12,650$502.35$82.00MRK
3$13,941$493.21$14,407$694.19$466.00MRK
4$15,377$460.17$16,585$967.82$1.2KMRK
5$16,880$426.93$19,342$1,363.89$2.5KMRK
6$18,456$394.21$22,913$1,947.19$4.5KMRK
7$20,110$362.53$27,662$2,823.89$7.6KMRK
8$21,850$332.27$34,159$4,173.35$12.3KMRK
9$23,683$303.66$43,337$6,308.80$19.7KMRK
10$25,618$276.84$56,776$9,798.13$31.2KMRK

SDXOF vs MRK: Complete Analysis 2026

SDXOFStock

Sodexo S.A. develops, manages, and delivers on-site, benefits and rewards, and personal and home services worldwide. It provides various on-site services, which includes corporate Services, energy and resources, government and agencies, sports and leisure, and other services; healthcare and seniors; and learning solutions to schools and universities. The company also provides food services comprising retail services and brands, food delivery, and meal and food vouchers, as well as digital food ordering services; benefits and rewards services, such as employee benefits, incentive and recognition programs, employee mobility, expense management, and public benefits; and personal and home services, including childcare, concierge, and in-home care services for seniors and their families. In addition, it offers facility management services, including technical service management, assets management, building maintenance, access control, deep cleaning, energy management, space planning, project management, front-of-house services, grounds maintenance, waste management, HVAC systems, mail management, commercial cleaning, workspace management and pest control. services. The company was formerly known as Sodexho Alliance and changed its name to Sodexo S.A. in 2008. Sodexo S.A. was founded in 1966 and is headquartered in Issy-les-Moulineaux, France.

Full SDXOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SDXOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SDXOF vs SCHDSDXOF vs JEPISDXOF vs OSDXOF vs KOSDXOF vs MAINSDXOF vs JNJSDXOF vs ABBVSDXOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.